Efficacy of heat-treated Lacticaseibacillus paracasei PS23 for individuals with long coronavirus disease-19 syndrome: a double-blinded randomized control pilot study
Abstract
Long coronavirus disease (long COVID) refers to symptoms that persist beyond the acute phase of SARS-CoV-2 infection. This study applied the World Health Organization (WHO) definition, which identifies post-COVID-19 condition as symptoms lasting at least two months and beginning around three months after confirmed infection. Given limited evidence on probiotic use for long COVID, we conducted a double-blind, randomized, placebo-controlled trial to evaluate the effects of heat-treated Lacticaseibacillus paracasei PS23 (HT-PS23) in individuals with confirmed COVID-19 and self-reported prolonged symptoms. Thirty-nine eligible participants were randomly assigned to receive either the heat-treated Lacticaseibacillus paracasei PS23 (HT-PS23) or placebo for six weeks. Assessments included validated neuropsychological tests (including executive function and working memory using Color Trails 1&2 and Digit Span and Coding), self-reported symptom scales of depression, anxiety, and quality of life, and blood biomarkers related to inflammation, immune response, and stress (e.g. cortisol, IFN-γ zonulin). After the six-week trial, HT-PS23 group showed notable improvements in cortisol level (p = 0.006), a reduction in errors of CTT2 (p = 0.018), and symptom severity related to breathing difficulties (p = 0.016) and appetite loss (p = 0.030) compared to the placebo group. HT-PS23 may be a feasible and well-tolerated intervention for relieving cognitive or physical symptoms associated with…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- Promising Sources of Plant-Derived Polyunsaturated Fatty Acids: A Narrative Review
- Effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kidney disease: Systematic review and meta-analysis of randomized controlled trials
- Effect of omega-3 fatty acids on cognition: an updated systematic review of randomized clinical trials
- The role of omega-3 polyunsaturated fatty acid supplementation in the management of type 2 diabetes mellitus: A narrative review
- Paucity of evidence for a relationship between long-chain omega-3 fatty acid intake and chronic obstructive pulmonary disease: a systematic review
- Omega-3 fatty acid nanocarriers: Characterization and potential applications
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.